Funicular Fund, LP files SEC Form 4 disclosures for ARCA biopharma, Inc.. They have made 17 open-market trades across 2 companies since 2020, most recently 2022-05-16.
CIK 0001752618
17 open-market purchases totalling $1.8M since 2020, never a sale. Across 17 scored buys the stock is up 7.3% at ninety days, and 3.9 points ahead of the S&P over the same stretch.
17 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 41% | 41% | 71% |
| Avg Move | -1.2% | +1.7% | +7.3% |
| Alpha | +0.8% | +5.1% | +3.9% |
| Scored | 17 | 17 | 17 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABIO | BUY | 2022-05-12 | 2022-05-16 | $2.29 | $356K | +2.3% | -3.6% | +4.0% |
| ABIO | BUY | 2022-05-10 | 2022-05-11 | $2.29 | $160K | +1.8% | +3.1% | +6.6% |
| ABIO | BUY | 2022-05-05 | 2022-05-09 | $2.28 | $526K | +0.0% | +2.6% | +3.5% |
| ABIO | BUY | 2022-04-28 | 2022-05-02 | $2.32 | $132K | -1.7% | -0.2% | +3.2% |
| ABIO | BUY | 2022-04-18 | 2022-04-20 | $2.31 | $21K | -1.7% | -3.7% | +0.4% |
| ABIO | BUY | 2022-04-04 | 2022-04-07 | $2.26 | $553K | +3.8% | -3.4% | +5.9% |
| ISIG | BUY | 2020-09-23 | 2020-09-24 | $0.62 | $2K | -3.1% | +48.4% | +35.2% |
| ISIG | BUY | 2020-09-11 | 2020-09-14 | $0.62 | $9K | -1.6% | +11.1% | +47.6% |
| ISIG | BUY | 2020-05-20 | 2020-05-21 | $0.64 | $5K | +4.0% | +27.1% | +26.1% |
| ISIG | BUY | 2020-05-07 | 2020-05-08 | $0.64 | $31 | -4.4% | +4.4% | +25.4% |
| ISIG | BUY | 2020-04-15 | 2020-04-16 | $0.65 | $3K | -5.0% | -5.8% | +26.1% |
| ISIG | BUY | 2020-03-24 | 2020-03-25 | $0.65 | $7K | +5.6% | -4.2% | +10.6% |
| ISIG | BUY | 2020-03-05 | 2020-03-06 | $0.75 | $5K | -15.5% | +1.4% | -4.1% |
| ISIG | BUY | 2020-02-26 | 2020-02-27 | $0.75 | $2K | +3.9% | -1.6% | -14.5% |
| ISIG | BUY | 2020-02-24 | 2020-02-25 | $0.77 | $10K | -2.9% | -17.1% | -16.3% |
| ISIG | BUY | 2020-02-13 | 2020-02-14 | $0.78 | $6K | -8.9% | -24.5% | -18.5% |
| ISIG | BUY | 2020-01-27 | 2020-01-28 | $0.78 | $20K | +3.8% | -5.0% | -16.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.